Rongrong Wu

Roswell Park Comprehensive Cancer Center

Also affiliated with Tokyo Medical University, Tokyo Medical University Hospital, University at Buffalo, State University of New York

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “TRIM37 Expression is Associated with Immune Suppression Poor Response to Neoadjuvant Chemotherapy and Worse Survival in ER-Positive/HER2-Negative Breast Cancer”.

TRIM37 Expression is Associated with Immune Suppression Poor Response to Neoadjuvant Chemotherapy and Worse Survival in ER-Positive/HER2-Negative Breast Cancer

Annals of Surgical Oncology(2025)10.1245/s10434-025-18764-x

N/A

0DataRank · unranked

1 citations

Rongrong Wu, Masayuki Nagahashi, John M.L. Ebos, Takashi Ishikawa, Masafumi Shimoda +3 more

ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2– Breast Cancer: A New Role for ESR1?

Annals of Surgical Oncology(2025)10.1245/s10434-025-18377-4

N/A

0DataRank · unranked

0 citations

Kohei Chida, Rongrong Wu, Kohei Taniguchi, Amber McKenery, Brian Morreale +17 more